TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)

$14.13 -0.21 (-1.4644%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 86

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) News Sources

Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development

15-04-2026

yahoo.com

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

31-03-2026

yahoo.com

Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain

26-03-2026

yahoo.com

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026

23-03-2026

yahoo.com

TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch

23-03-2026

yahoo.com

Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026

18-03-2026

yahoo.com

Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

17-03-2026

yahoo.com

OTC Markets Hosts Virtual Investor Presentation with Dr. Seth Lederman, Co-Founder, CEO, and Chairman of Tonix Pharmaceuticals, and David Bautz, PhD, Senior Analyst at Zacks SCR

16-03-2026

yahoo.com

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

13-03-2026

yahoo.com

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

12-03-2026

yahoo.com

TNXP stock
TNXP stock price
TNXP stock price today
TNXP stock prediction
TNXP earnings date
TNXP news
TNXP price
TNXP share
TNXP share price
TNXP shares
TNXP ceo
TNXP premarket
$TNXP
TNXP ticker
TNXP after hours
TNXP stock
TNXP stock price
TNXP stock price today
TNXP stock prediction
TNXP earnings date
TNXP news
TNXP price
TNXP share
TNXP share price
TNXP shares
TNXP ceo
TNXP premarket
$TNXP
TNXP ticker
TNXP after hours

TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) Sentiment Trend

View FAQ

TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) FAQs

toggle

What is the current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?

The current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is $14.13.


toggle

TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) absolute price change since previous trading day?

The absolute price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is $-0.21.


toggle

TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) percentage price change since previous trading day?

The percentage price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is -1.4644%.


toggle

What is the most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?

The most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is 86 out of 100.


toggle

What is the most recent average sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?

The most recent sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is .


SEC-8K** Filing Available For TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.